Key result
High-pitch cardiac CTA achieves 100% diagnostic accuracy with low radiation in neonates with CHD.
Why the study?
Multimodal therapy strategies for congenital heart disease have increased demand for noninvasive imaging in neonates, where test bolus or bolus tracking scans account for a relevant share of cardiac CT radiation exposure. This study sought to further optimize cardiac CT radiation dose by omitting the test bolus or bolus tracking scan.
Does omitting the test bolus or bolus tracking scan during high-pitch cardiac CT angiography optimize radiation dose while maintaining image quality and diagnostic accuracy in neonates with congenital heart disease?
Cohort (n=25)
Does omitting the test bolus or bolus tracking scan during high-pitch cardiac CT angiography optimize radiation dose while maintaining image quality and diagnostic accuracy in neonates with congenital heart disease?
Omitting test bolus or bolus tracking in neonatal cardiac high-pitch CTA achieves low radiation exposure (median 0.66 mSv) while maintaining very good image quality and 100% surgical diagnostic accuracy.
Answers are grounded in this paper and cite their sources.
Supports ultra-low-dose neonatal cardiac CTA without bolus tracking; leaves open prospective validation before routine adoption.
RATIONALE AND OBJECTIVES: Congenital heart diseases (CHD) belong to the leading causes of infant mortality worldwide. Prognostic improvements result from multimodal therapy strategies leading to an increased demand for noninvasive imaging. The aim of the study was to further optimize cardiac CT radiation dose by omitting the test bolus or bolus tracking scan, which can have a relevant share of radiation exposure, especially in neonates. MATERIALS AND METHODS: This retrospective study included 25 neonates with CHD who received a CT angiography (CTA) from 2009 to 2018. The examinations were performed as a high-pitch CTA (pitch 3.4, 80 kV) with manual contrast administration (1.5 ml/kg body weight) and fixed scan delay depending on the respective heart defect. Diagnosis, adverse events, radiation dose parameters, objective (contrast-to-noise ratio) and subjective (4-point Likert scale) image quality as well as diagnostic accuracy compared to intraoperative findings was assessed. RESULTS: ) was 0.50 mGy (range, 0.15-0.94), the median dose-length product was 8 mGy × cm (range, 3-17). The estimation of the effective dose by Monte Carlo simulation revealed lower median dose levels 0.66 mSv (range, 0.25-1.40 mSv) than previously published in comparable groups. All examinations achieved a very good mean image quality score of 1.2 ± 0.4 with only minimal image noise and mean contrast-to-noise ratio of 16.1 ± 7.0. Diagnostic accuracy was 100 % as cardiac anatomy revealed no new diagnoses or significant differences in the subsequent cardiac surgery. CONCLUSION: Cardiac high-pitch CTA of neonates with CHD can be performed safely and dose-reducing without additional test bolus or bolus tracking scan. With very good image quality, it provides a detailed insight into the cardiac anatomy and thus enables a differentiated, noninvasive therapy planning.
No takes yet. Share an insight, caveat, or question.
Schindler et al. (2019) conducted a cohort in Neonates with congenital heart disease (n=25). High-pitch cardiac CT angiography without test bolus or bolus tracking (fixed scan delay) vs. Intraoperative findings (for diagnostic accuracy) was evaluated on Radiation dose (effective dose), image quality, and diagnostic accuracy compared to intraoperative findings. High-pitch cardiac CTA omitting test bolus/bolus tracking achieved 100% diagnostic accuracy and a median effective dose of 0.66 mSv in neonates with CHD.
Synapse has enriched 10 related papers. Consider them for comparative context: